ライフサイエンスコーパス: early diagnosis

1 rests in developing new cancer therapies and early diagnosis.

2 have relevant translational implications in early diagnosis.

3 be included in the diagnostic algorithm for early diagnosis.

4 ptomatically, highlighting the importance of early diagnosis.

5 explore the potential biomarkers of AIS for early diagnosis.

6 yocarditis have heightened the importance of early diagnosis.

7 establish criteria allowing an accurate and early diagnosis.

8 a potential tool of significant promise for early diagnosis.

9 lness but proved unhelpful in clarifying the early diagnosis.

10 molecular level and has a high potential on early diagnosis.

11 and mortality, emphasizing the importance of early diagnosis.

12 d unpleasant odors may provide a window into early diagnosis.

13 there is need for alternative biomarkers for early diagnosis.

14 oup at higher risk of melanoma may assist in early diagnosis.

15 opriate strategy for improving breast cancer early diagnosis.

16 risk assessment, and tailored strategies for early diagnosis.

17 Early diagnosis, a key to better outcomes, still remains

18 st cancer among women, improved capacity for early diagnosis among health workers, and the creation o

19 H has become more complex given the focus on early diagnosis, an increased number of available therap

20 hild's future literacy that could facilitate early diagnosis and access to crucial early intervention

21 cardiovascular performance is important for early diagnosis and accurate management of patients at r

22 omparable to that of the general population, early diagnosis and accurate risk profiling are essentia

23 king, such as targeted biopsy approaches for early diagnosis and active surveillance, in addition to

24 Early diagnosis and adequate staging are crucial for the

25 Early diagnosis and adequate treatment are essential in

26 ging appearance is essential to arrive at an early diagnosis and also to obviate biopsy in cases with

27 Early diagnosis and appropriate care can lead to prevent

28 Early diagnosis and appropriate intervention can be life

29 of AKT3 mutations is important for providing early diagnosis and appropriate management of affected i

30 Early diagnosis and appropriate treatment can prevent un

31 Early diagnosis and appropriate treatment of infections

32 infants with cystic fibrosis have access to early diagnosis and care.

33 Early diagnosis and complete surgical removal of the int

34 ophisticated imaging modalities, have led to early diagnosis and complex treatment.

35 ophagus is easily accessible with endoscopy, early diagnosis and curative treatment of esophageal can

36 Early diagnosis and echocardiographic detection of right

37 ss (PPLA) fatalities are decreasing owing to early diagnosis and effective treatments, PPLA-associate

38 tein biomarkers offers new opportunities for early diagnosis and efficient treatment of complex disea

39 these abnormalities in the brain to improve early diagnosis and help predict the disease course.

40 Short duration of symptoms, early diagnosis and high satisfaction with care predicte

41 es can help pinpoint relevant biomarkers for early diagnosis and improved prognosis of alcoholism and

42 to rise, partly due to the lack of effective early diagnosis and increasing environmental exposure to

43 ate of PDAC stems primarily from the lack of early diagnosis and ineffective treatment for advanced t

44 ogical changes of potential value to support early diagnosis and informed therapeutic decisions.

45 Early diagnosis and initiation of recommended therapy ar

46 munodeficiency virus (HIV) are contingent on early diagnosis and initiation of therapy.

47 r-patient technologies are needed to improve early diagnosis and intervention for patients with renal

48 carcinoma, could generate new strategies for early diagnosis and intervention.

49 there is no known cure for Type 2 diabetes, early diagnosis and interventions are critical to preven

50 d mortality in a wide range of patients, and early diagnosis and management are a challenge.

51 Early diagnosis and management is required due to risk o

52 marker, plays a critical role in screening, early diagnosis and management of breast cancer.

53 Early diagnosis and management of HF could help reduce t

54 Early diagnosis and management of this rare condition is

55 rtant to be familiar with the entity for its early diagnosis and management.

56 agnostic biomarkers for cGVHD are needed for early diagnosis and may guide identification of prognost

57 common congenital infections may facilitate early diagnosis and may, at times, lead to prompt initia

58 review the state-of-the-art technologies for early diagnosis and minimally invasive treatment, which

59 These devices can be very useful in the early diagnosis and monitoring of a malignant disease.

60 e most sensitive and predictable test for an early diagnosis and monitoring of disease progression.

61 new rapid and accurate detection systems for early diagnosis and monitoring of minimal residual disea

62 ammation and remodeling can potentially help early diagnosis and monitoring of the effects of therape

63 c imaging and late gadolinium enhancement in early diagnosis and noninvasive follow-up of ARVC patien

64 s prevention and underline the importance of early diagnosis and of early and continuous treatment.

65 be attributable to differences in access to early diagnosis and optimum treatment.

66 enomic disorders may provide opportunity for early diagnosis and personalized interventions to mitiga

67 urrent understanding of lung carcinogenesis, early diagnosis and personalized therapy.

68 videnced with this new device, assisting the early diagnosis and prevention of periodontal disease.

69 cipants were recruited on admission into the Early Diagnosis and Preventive Treatment Clinic, an outp

70 s are further establishing its importance in early diagnosis and prognosis.

71 Early diagnosis and prompt management of adverse events

72 Moreover, early diagnosis and prompt treatment might help visual i

73 Early diagnosis and risk stratification is of clinical i

74 se progression offers an opportunity for the early diagnosis and staging using a noninvasive imaging

75 ncer diagnosis may significantly improve the early diagnosis and subsequent treatment.

76 ensitive detection of small, deep tumors for early diagnosis and surgical interventions remains a cha

77 Sepsis is a medical emergency demanding early diagnosis and tailored antimicrobial therapy.

78 signs of possible encephalitis to facilitate early diagnosis and targeted treatment.

79 s may help to reduce mortality rates through early diagnosis and the development of new anticancer th

80 nslatable, these markers could contribute to early diagnosis and the development of novel therapies o

81 G-6-P-dehydrogenase activity will facilitate early diagnosis and therapeutic intervention of this nov

82 ntifying HCM patients who might benefit from early diagnosis and therapeutic interventions.

83 the newer mapping techniques with respect to early diagnosis and therapy of CS will have to be determ

84 d detection of serum Aspergillus DNA for the early diagnosis and therapy of invasive aspergillosis (I

85 mother and discuss the role of radiology in early diagnosis and timely management.

86 A biomarker for ICP would be invaluable for early diagnosis and treatment and to enable its differen

87 GCS is the best predictor of mortality: early diagnosis and treatment are critical.

88 Early diagnosis and treatment are determinant for progno

89 Early diagnosis and treatment are essential to maximize

90 Therefore, early diagnosis and treatment are important.

91 Early diagnosis and treatment are necessary to prevent a

92 Early diagnosis and treatment can prevent or delay progr

93 Early diagnosis and treatment can prevent progression of

94 In such a situation, early diagnosis and treatment is crucial for the surviva

95 Early diagnosis and treatment is prudent in such neoplas

96 high level of clinical suspicion is key for early diagnosis and treatment of botulism.

97 findings suggest that better initiatives for early diagnosis and treatment of COPD are needed.

98 cancer stem cells will provide insight into early diagnosis and treatment of HNSCC.

99 the development of novel strategies for the early diagnosis and treatment of hypertension and of pat

100 etection of infectious agents is critical in early diagnosis and treatment of infectious diseases.

101 etection of infectious agents is critical in early diagnosis and treatment of infectious diseases.

102 Early diagnosis and treatment of occult hernias are esse

103 Early diagnosis and treatment of PV complications may en

104 an joint diseases with unknown etiology, the early diagnosis and treatment of RA remains a challenge.

105 makes the receptor a promising target in the early diagnosis and treatment of several neurodegenerati

106 nvasive biomarker of acute AMR could lead to early diagnosis and treatment of this condition and impr

107 High degree of suspicion is required for early diagnosis and treatment of this condition.

108 normalities, and (3) the favorable effect of early diagnosis and treatment regardless of treatment mo

109 ntralized approach across the continuum from early diagnosis and treatment to community awareness and

110 Early diagnosis and treatment with appropriate antimicro

111 Early diagnosis and treatment, as well as long-term moni

112 hic findings of these conditions may lead to early diagnosis and treatment, resulting in improved pat

113 A favorable prognosis is contingent upon early diagnosis and treatment.

114 This necessitates early diagnosis and treatment.

115 tection, with important implications for the early diagnosis and treatment.

116 laboratory and radiologic tools, aids in the early diagnosis and treatment.

117 schemic penumbra which are very important in early diagnosis and treatment.

118 ish programmes aiming for sepsis prevention, early diagnosis, and adequate treatment.

119 Risk stratification, early diagnosis, and appropriate intervention are critic

120 Efficient prevention, early diagnosis, and effective treatment are essential t

121 t appropriate strategies for the prevention, early diagnosis, and management of potential radiation i

122 /IgG RNA ratio markedly improve delineation, early diagnosis, and monitoring of IgG4-RD of the biliar

123 Medical imaging is essential to screening, early diagnosis, and monitoring responses to cancer trea

124 public and political demand, on prevention, early diagnosis, and patient experience during and after

125 cidence is important to optimize prevention, early diagnosis, and treatment of in situ and invasive m

126 Awareness of the ocular phenotype may aid early diagnosis, appropriate genetic counseling, and mon

127 especially in the T60A patients, should aid early diagnosis as well as contribute to the understandi

128 periodontal knowledge and barriers hampering early diagnosis, as well as for adequate educational int

129 Early diagnosis begins with a medical history and involv

130 e; standardized screening tools that improve early diagnosis; biomechanical strategies that improve s

131 Although early diagnosis by echocardiography may potentially play

132 olymorphism (SNP) detection is important for early diagnosis, clinical prognostics, and disease preve

133 An early diagnosis could help prevent these sequelae and pr

134 The effects of early diagnosis, dermatologic presentation, and antifung

135 Clinical breast examination may improve early diagnosis directly by finding breast cancers at ea

136 n ALS-FTD may have clinical implications for early diagnosis, disease management and care planning an

137 Biofluids are key to early diagnosis due to their ease of collection and inti

138 It calls for more attention on early diagnosis, early treatment and prescription of app

139 Poor prognosis and difficult early diagnosis emphasise the importance of preventive t

140 s our body vulnerable for infections, making early diagnosis essential.

141 are discussed, focusing on the importance of early diagnosis for clinical and therapeutic reasons.

142 es and on new genetic therapies that require early diagnosis for effectiveness.

143 is a highly angiogenic cancer, necessitating early diagnosis for positive prognosis.

144 Its early diagnosis has been remained a prime focus amongst

145 ogression of latent systemic disease, making early diagnosis important.

146 y biomarkers that may have applicability for early diagnosis, improved staging, and prognostic strati

147 Early diagnosis improves the effectiveness of the therap

148 ave important translational implications for early diagnosis in a subset of Alzheimer's disease patie

149 ction of DNA and holds a great potential for early diagnosis in gene-related diseases.

150 eimer's disease biomarkers are important for early diagnosis in routine clinical practice and researc

151 This early diagnosis is becoming possible using the real-time

152 Early diagnosis is critical for survival, but it is ofte

153 Accurate early diagnosis is critical to patient survival, managem

154 Early diagnosis is critical to prevent life-threatening

155 n men, preceded only by lung cancer, and its early diagnosis is crucial for a successful treatment, t

156 Early diagnosis is essential for implementation of contr

157 nd mortality associated with kidney disease, early diagnosis is important and should be pursued in at

158 Early diagnosis is important, as it can lead to hepatic

159 Therefore, development of new methods for early diagnosis is instantly required.

160 Early diagnosis is key to optimal therapeutic success, p

161 Early diagnosis is necessary to reduce the mortality and

162 have allowed accurate late-stage prognosis, early diagnosis is still a major challenge.

163 The lack of sensitive methods for early diagnosis is the most common cause of delay.

164 Early diagnosis is therefore essential.

165 ut its importance, from the point of view of early diagnosis, is not negligible and patients with a r

166 gnizing these syndromes is important because early diagnosis may lead to instituting specific therapy

167 Despite improved survival with early diagnosis, medical management, and dietary treatme

168 Survival could be improved by early diagnosis, new treatments, and improved case manag

169 in human blood serum is highly in demand for early diagnosis of acute myocardial infarction (AMI).

170 However, early diagnosis of AD is challenging due to the lack of

171 The results may facilitate the early diagnosis of adverse drug events in clinical appli

172 Our aim was to define CT skills in early diagnosis of AIS, to define its contribution to pa

173 conjectured to potentially contribute to the early diagnosis of Alzheimer patients by diffusion MRI.

174 C as an adjunct or alternative to cTn in the early diagnosis of AMI.

175 thmia burden highlights the importance of an early diagnosis of arrhythmic events in such patients to

176 That results may be useful for an early diagnosis of asthma.

177 Early diagnosis of atrial fibrillation, ideally before t

178 g with the ICG pHLIP peptide offers improved early diagnosis of bladder cancers and may also enable n

179 s with brain metastasis (BCBM) may allow for early diagnosis of brain metastasis and/or help for trea

180 Development of regular screening tests for early diagnosis of breast cancer is a challenge.

181 The early diagnosis of breast cancer is crucial for the succ

182 Strategies for early diagnosis of breast cancer should be regarded as a

183 iosensor device aimed for self-screening and early diagnosis of breast cancer.

184 be applied as a novel clinical tool for the early diagnosis of breast cancer.

185 The only hope for early diagnosis of cancer in near future is by the detec

186 h below the range 1-10 muM pertinent for the early diagnosis of cancer in urinary samples.

187 Early diagnosis of cancer is decisive for its successful

188 , and potentially screen individuals for the early diagnosis of cancer.

189 oscopy (biopsies) are too not conclusive for early diagnosis of cancer.

190 e offers unique potential for convenient and early diagnosis of CD.

191 systematically searched the literature about early diagnosis of cerebral palsy in MEDLINE (1956-2016)

192 To develop an algorithm for accurate and early diagnosis of CJD by using the RT-QuIC assay on CSF

193 lic events secondary to cardiac myxoma, thus early diagnosis of conjunctival myxoma can prevent poten

194 Early diagnosis of CRS is important for appropriate mana

195 ds are recognized as critical biomarkers for early diagnosis of dairy cow metabolic diseases.

196 ings can be potentially helpful in making an early diagnosis of dengue fever.

197 patients' blood samples and can be used for early diagnosis of dengue infection.

198 early sensory activity could be utilized for early diagnosis of developmental disorders.

199 Early diagnosis of diabetic retinopathy (DR) is vital bu

200 It is believed that routine and early diagnosis of disease could be possible through suc

201 s future point of care for fast and reliable early diagnosis of diseases related to the presence of D

202 r sensitivity, which is highly desirable for early diagnosis of diseases.

203 ed pH sensing platform in bio-fluids for the early diagnosis of diseases.

204 early marker for future DLB, which would aid early diagnosis of DLB and identify those at high risk.

205 Therefore, rapid, accurate, and early diagnosis of Ebola virus disease (EVD) is critical

206 High analytical sensitivity is important for early diagnosis of EVD.

207 Early diagnosis of fetal infection and consequent rapid

208 e, the devised chemosensors are suitable for early diagnosis of fungal infections caused by Candida s

209 these polyps can result in the prevention or early diagnosis of gastric carcinoma and also help in th

210 c DNA sequence is a central challenge in the early diagnosis of gene-related disease and biodefense a

211 Searching more specific biomarkers for early diagnosis of HCC in alcoholic cirrhosis is still w

212 ior viral load amplification, sufficient for early diagnosis of hepatitis B.

213 Early diagnosis of hepatobiliary cystadenocarcinoma is d

214 te characterization of cirrhotic nodules and early diagnosis of hepatocellular carcinoma (HCC) are of

215 pplement current screening modalities to aid early diagnosis of high-risk populations and assist the

216 d assessment of histidine as a biomarker for early diagnosis of histidinemia disease in new born chil

217 n with broad application, especially for the early diagnosis of HLB.

218 luminescence detection was developed for the early diagnosis of human cancer.

219 iRNAs) are potentially useful biomarkers for early diagnosis of human diseases.

220 retroviral therapy (ART) initiation requires early diagnosis of human immunodeficiency virus (HIV) in

221 l so that its utility as a clinical test for early diagnosis of IFI is questionable in the lung trans

222 e limits its utility as a screening tool for early diagnosis of IFI.

223 graft-reactive T and B cells allows for the early diagnosis of immune reactivity and therapeutic int

224 fected testicles can be a useful tool in the early diagnosis of incomplete testicular torsion.

225 Early diagnosis of infective endocarditis (IE) is based

226 of circulating Mucorales DNA (cmDNA) for the early diagnosis of IWM in those patients and report the

227 ificity (96.45%) of 3-Nty as a biomarker for early diagnosis of liver cirrhosis with MHE in patients.

228 f 3-nitrotyrosine (3-Nty) as a biomarker for early diagnosis of liver cirrhosis with minimal hepatic

229 The early diagnosis of malignancy is the most critical facto

230 n of microRNA panels in body fluids promises early diagnosis of many diseases, including cancer or ac

231 ve method is in great need for immediate and early diagnosis of meningitis.

232 Early diagnosis of metastatic infection is crucial, beca

233 In the early diagnosis of myocardial infarction (MI), beyond do

234 al parameters, we developed an algorithm for early diagnosis of NCPH in HIV.

235 evelopment of a screening tool to allow very early diagnosis of NEC.

236 and therapeutic options that will speed the early diagnosis of neurodegenerative diseases and their

237 Early diagnosis of neurological disorders would greatly

238 ence, JXG and NA appear helpful in improving early diagnosis of NF1 in young children and infants.

239 mylase enzyme in urine and serum samples for early diagnosis of Pancreatitis disease.

240 tivity (96.88%) and specificity (94.41%) for early diagnosis of pancreatitis diseases.

241 te-specific antigen (PSA) in human serum for early diagnosis of PCa.

242 )F-DTBZ PET was as an excellent tool for the early diagnosis of PD.

243 LR-OCT may ultimately aid in the early diagnosis of postintubation subglottic injury and

244 ant biomarker in urine and serum samples for early diagnosis of preeclampsia, a life-threatening hype

245 extreme risk with TBP and SDDI assisted with early diagnosis of primary melanoma.

246 breast cancer, MR imaging screening improves early diagnosis of prognostically relevant breast cancer

247 Early diagnosis of prostate cancer (PCa) is critical for

248 biosensor can be applied as a new method for early diagnosis of prostate cancer.

249 hemiluminescence detection was developed for early diagnosis of prostate cancer.

250 This can be harnessed for early diagnosis of proteinopathies and for drug/vaccine

251 An early diagnosis of RA is essential to prevent the develo

252 s emerged as a potentially powerful tool for early diagnosis of rheumatic heart disease (RHD).

253 nal brain biomarkers, limiting the chance of early diagnosis of schizophrenia.

254 Early diagnosis of SCID through population-based screeni

255 A noninvasive diagnostic test could improve early diagnosis of sCJD and, by screening donations, mit

256 n of PLT-I and NEUT-Y show potential for the early diagnosis of sepsis post-burn injury.

257 w potential as biomarkers for the prediction/early diagnosis of sepsis postburn injury and neutrophil

258 Procalcitonin did not assist in the early diagnosis of sepsis.

259 3 in saliva that can potentially be used for early diagnosis of stomach cancer.

260 ith a potential application for non-invasive early diagnosis of stomach cancer.

261 Early diagnosis of T. cruzi infection is crucial.

262 d distribution could provide the means of an early diagnosis of tau-associated diseases.

263 Early diagnosis of TB results in early treatment and imp

264 Early diagnosis of testicular rupture may lead to the sa

265 g of RA have contributed significantly to an early diagnosis of the disease.

266 Early diagnosis of these markers can greatly improve the

267 The development of a tangible protocol for early diagnosis of this disease remains a major challeng

268 s great need for noninvasive tools improving early diagnosis of this rejection type.

269 significantly increases the possibility for early diagnosis of tuberculosis, but IGRAs alone cannot

270 ysis of rotational mechanics may help in the early diagnosis of ventricular dysfunction.

271 ional CT images can increase the accuracy of early diagnosis of visceral pleural invasion by NSCLC th

272 gists have a significant role to play in the early diagnosis of VVAD.

273 Early diagnosis of Wilson's disease is crucial to ensure

274 Early diagnosis offers an opportunity for a intrauterine

275 We found elevated risk for AML for overall, early diagnosis periods and longer follow-up times in bo

276 of tremors is disease specific, accurate and early diagnosis plays an important role in tremor manage

277 uble Abeta oligomers is highly desirable for early diagnosis prior to the manifestation of a clinical

278 gnaling phenotypes with predictive value for early diagnosis, prognosis, or relapse and a thorough ch

279 nt of oxidative stress-related biomarkers in early diagnosis, prognostication, and/or in evaluating r

280 , and to design evidence-based screening and early diagnosis programmes to address the growing burden

281 Early diagnosis, prompt initiation of supportive medical

282 tions and is emerging as a powerful tool for early diagnosis, quantification of disease extent, thera

283 Early diagnosis remains a task of upmost importance for

284 validated for use in these patients; hence, early diagnosis remains difficult.

285 Early diagnosis saves lives and reduces onward transmiss

286 unity-based triage programme and a practical early diagnosis scheme within existing multilevel health

287 Early diagnosis, selection of appropriate antimicrobials

288 An accurate early diagnosis should forestall unnecessary later surge

289 a crucial role in patient care by providing early diagnosis through interpretation of imaging studie

290 Improvements in early diagnosis through the use of sophisticated imaging

291 igger the need of appropriate biomarkers for early diagnosis, thus countermeasure can be taken.

292 An early diagnosis to direct appropriate therapy has been s

293 ecific early intervention that should follow early diagnosis to optimize neuroplasticity and function

294 ET) and single-photon emission CT (SPECT) to early diagnosis, treatment and prognostication.

295 r the development of functional, sustainable early diagnosis, treatment and supportive care programme

296 f low concentration of DLD-1 cancer cells in early diagnosis using the electrochemical impedance meth

297 patients with leprosy promises to strengthen early diagnosis, while preventive chemotherapy will redu

298 The combination of early diagnosis with effective therapies should change t

299 e major presenting symptom is paramount, and early diagnosis with individualised treatment and follow

300 Standardized care following early diagnosis would reduce disparities in clinical car